BORTEZOMIB FOR INJECTION SDZ

Google image searchProduct monograph

Active ingredient

bortezomib (bortezomib mannitol boronic ester), 3.5 MG/VIAL

DIN: 02503352

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS

Description: SINGLE USE VIAL

Schedule: Prescription

Company: SANDOZ CANADA INCORPORATED

Date: 31-JAN-2022

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
• L01XG — Proteasome inhibitors (ATC, ATC/DDD)
• L01XG01 — BORTEZOMIB (ATC/DDD)

Reference brand drug: Velcade

External Links for Bortezomib For Injection Sdz

Search on Google

• Bortezomib For Injection Sdz side effects
• Bortezomib For Injection Sdz dosage
• bortezomib side effects
• bortezomib dosage

Sandoz Canada Incorporated

Go to Sandoz website to see drug product details. Sometimes you can find bortezomib for injection sdz photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.